9 METERS BIOPHARMA INC (NMTR)
US6544052086 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to NMTR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.58. This target is 14557.2% above the current price.
NMTR was analyzed by 11 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about NMTR.
In the previous month the buy percentage consensus was at a similar level.
NMTR was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-05-18 | Citigroup | Maintains | Neutral -> Neutral |
| 2023-03-20 | Truist Securities | Downgrade | Buy -> Hold |
| 2023-02-13 | Citigroup | Initiate | Neutral |
| 2022-11-10 | BMO Capital | Maintains | Outperform |
| 2022-09-27 | Oppenheimer | Maintains | Outperform |
| 2022-07-01 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-06-22 | BMO Capital | Maintains | Outperform |
| 2022-06-22 | Truist Securities | Maintains | Buy |
| 2021-07-08 | BMO Capital | Initiate | Outperform |
| 2021-06-04 | Citigroup | Initiate | Buy |